Trials / Conditions / Generalized Anxiety Disorder

Generalized Anxiety Disorder

316 registered clinical trials studyying Generalized Anxiety Disorder — 52 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	A Phase 2a Efficacy, Safety, Tolerability, and PK Study of SYT-510 in Participants With Generalized Anxiety Di NCT07478744	Synendos Therapeutics AG	Phase 2
Not Yet Recruiting	RE104 Safety and Efficacy Study in Generalized Anxiety Disorder NCT07489651	Reunion Neuroscience Inc	Phase 2
Not Yet Recruiting	Mapsd Dual-target cTBS (Auditory Cortex and M1) for Generalized Anxiety Disorder NCT07403591	Anhui Medical University	N/A
Not Yet Recruiting	Pharmacokinetic Study of Buagafuran Capsules in Participants With Hepatic Impairment and Normal Hepatic Functi NCT07457190	Beijing Union Pharmaceutical Factory Ltd	Phase 1
Not Yet Recruiting	Metacognitive Therapy Compared to Cognitive-behavioral Therapy NCT07382323	Karolinska Institutet	N/A
Not Yet Recruiting	Ultra-brief Psychological Treatments for Emotional Symptoms and Disorders NCT06909669	Universidad de Córdoba	N/A
Not Yet Recruiting	Testing a Precision Psychotherapy System for Low-income Patients NCT05118594	National Council of Scientific and Technical Research, Argentina	N/A
Not Yet Recruiting	Electroacupuncture for Generalized Anxiety Disorder: Clinical Efficacy and Neuroimaging Mechanisms NCT07392645	Lishu Gao	N/A
Recruiting	Internet-Delivered Cognitive Behavioral Intervention for Youths With Anxiety Disorders NCT06661460	Lund University	N/A
Recruiting	Implementing Team-Based Treatment for Pediatric Anxiety in Community Mental Health Settings NCT06934525	Bradley Hospital	N/A
Recruiting	Cohort Study on Medical Students' Mental Health NCT07305701	Centre Hospitalier Régional d'Orléans	—
Recruiting	Prospective Clinical Trial of Crisugabalin Capsules in the Treatment of Generalized Anxiety Disorder NCT07330648	Anhui Medical University	Phase 2
Recruiting	Navigated cTBS for the Treatment of Generalized Anxiety Disorder NCT07121712	WANG KAI	N/A
Recruiting	Stepped Versus Stratified Care for Anxiety Disorders in Youth NCT06942429	Region Skane	N/A
Recruiting	Mindful Self-compassion for Anxiety and Depression: Impact of Delivery Method NCT07028216	Georgetown University	N/A
Recruiting	Transdiagnostic Internet-delivered Intervention for Adolescents With Anxiety and Depression NCT06724666	Babes-Bolyai University	N/A
Recruiting	Teletherapy vs. In-Person Cognitive Behavioral Therapy for Generalized Anxiety Disorder NCT07119515	Government College University Faisalabad	N/A
Not Yet Recruiting	Understanding of Participation Trends Within Generalized Anxiety Disorder Patients Involved in Clinical Trials NCT06254157	Power Life Sciences Inc.	—
Enrolling By Invitation	Metacognitive Therapy for Depression and Generalized Anxiety Disorder in Primary Care, Blended Version of Medi NCT06928428	Region Stockholm	N/A
Recruiting	RCT of Short-Term Psychoanalytic vs. Cognitive Behavioral Therapy for GAD NCT06831708	Beykoz University	N/A
Recruiting	Search for Novel Transcranial Magnetic Stimulation (TMS) Targets for Mental Illness NCT06376734	Brigham and Women's Hospital	Phase 2
Recruiting	A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Panorama) NCT06809595	Definium Therapeutics US, Inc.	Phase 3
Recruiting	Neurofeedback Enhanced Cognitive Reappraisal Training - Phase 4 NCT06563310	University of Michigan	N/A
Recruiting	Use of CBD in the Treatment of Anxiety NCT06672666	University of Florida	Phase 2
Completed	Treating Young Adult Generalized Anxiety Disorder With Text-Message Delivered Cognitive Behavioral Therapy NCT06774573	The University of Tennessee, Knoxville	N/A
Recruiting	A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Voyage) NCT06741228	Definium Therapeutics US, Inc.	Phase 3
Not Yet Recruiting	Efficacy and Safety of Inhaled NC-107 As Compared to Placebo After 4 Weeks of Treatment in Patients with Anxie NCT06656806	Trinity Hypertension & Metabolic Research Institute	EARLY_Phase 1
Not Yet Recruiting	Effects of rTMS on the Anxiety State of Older Patients With GAD NCT05883774	Yi Yang	N/A
Recruiting	Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder NCT06701903	Intra-Cellular Therapies, Inc.	Phase 2
Recruiting	Internet-delivered Cognitive-Behavioral Therapy for Adolescents With Autism and Anxiety NCT06537128	Baylor College of Medicine	N/A
Recruiting	Adjunctive Treatment With L-methylfolate for Treatment-Resistant Generalized Anxiety Disorder: a Pilot Study NCT06218030	Queen's University	Phase 4
Recruiting	Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder NCT06480383	Intra-Cellular Therapies, Inc.	Phase 2
Withdrawn	Cognitive Behavioral Therapy (CBT) for Late Life Anxiety NCT05380115	Wake Forest University Health Sciences	N/A
Enrolling By Invitation	Operation of Brain Stimulation Equipment Under Remote Viewing Effectiveness Registry NCT06512324	Biomedical Discoveries and Neuroscientific Foundations LLC	—
Active Not Recruiting	The Effect of Psychoeducation Based on Acceptance and Commitment Therapy Applied to Patients Diagnosed With Ge NCT06972563	Arzu Çalışkan	N/A
Recruiting	The Effectiveness of Transdiagnostic CBT Protocol on Anxiety Disorders NCT06422728	Ibn Haldun University	N/A
Active Not Recruiting	A Study of a N, N-dimethyltryptamine (DMT) Analog (CYB004) in Participants With Generalized Anxiety Disorder ( NCT06051721	Cybin IRL Limited	Phase 2
Recruiting	Massage for GAD: Neuroimaging and Clinical Correlates of Response NCT06506253	University of Utah	N/A
Completed	Neurofeedback Enhanced Cognitive Reappraisal Training NCT06132659	University of Michigan	N/A
Unknown	Behavioural Experiments for Generalized Anxiety in Adolescents - Pilot Study NCT06282133	Universite du Quebec en Outaouais	N/A
Completed	CES for the Treatment of GAD in Young Adults NCT06124014	Electromedical Products International, Inc.	N/A
Recruiting	Trigeminal Nerve Stimulation in Treatment-resistant Generalized Anxiety Disorder: a Feasibility Study NCT06278909	Dr. Rafael Freire	N/A
Completed	Adaptation and Feasibility of the Community-Based Anxiety Program Tailored for Autism (CAPTA) NCT06046170	Baylor College of Medicine	N/A
Completed	Transcranial Direct Current Stimulation (tDCS) in Different Psychiatric Disorders NCT07452835	Menoufia University	N/A
Unknown	Transcutaneous Vagus Nerve Stimulation for Generalized Anxiety Disorder NCT06134323	Xijing Hospital	N/A
Active Not Recruiting	Evaluation of Family-Based Behavioral Treatments for Youth With Anxiety and Obsessive-Compulsive Disorder NCT05967468	Baylor College of Medicine	N/A
Completed	Pivotal RCT to Test Safety and Efficacy of Digital Therapeutics 'ANZEILAX' for Managing Generalized Anxiety Di NCT06010654	HAII corp.ltd	N/A
Recruiting	Phase 3 Clinical Trial of Buagafuran Capsules in the Treatment of GAD NCT06243640	Beijing Union Pharmaceutical Factory Ltd	Phase 3
Recruiting	Phase Ⅲ Clinical Trial of Buagafuran Capsules in the Treatment of GAD NCT06243614	Beijing Union Pharmaceutical Factory Ltd	Phase 3
Recruiting	A Study to Evaluate Efficacy and Safety of Toludesvenlafaxine Hydrochloride Sustained-release Tablets in Gener NCT05970510	Luye Pharma Group Ltd.	Phase 3
Completed	ENCALM: A Study of ENX-102 as a Monotherapy Treatment in Patients With Generalized Anxiety Disorder NCT05749055	Engrail Therapeutics INC	Phase 2
Unknown	Development of Online EMDR Therapy System and Its Comparative Testing With Face-to-Face EMDR Therapy for Treat NCT05785312	Khushal Khan Khattak Univeristy, Karak, Pakistan	N/A
Active Not Recruiting	Effects and Mechanisms of Change of Internet Delivered Cognitive Behavior Therapy for Generalized Anxiety Diso NCT05849493	Karolinska Institutet	N/A
Recruiting	Clinical Trial of Shugan Jieyu Capsule in Generalized Anxiety Disorder NCT05772104	Sichuan Jishengtang Pharmaceutical Co., Ltd.	Phase 3
Completed	Mental Health Assessment and Prescribing by Alberta Pharmacists NCT04410575	University of Alberta	N/A
Completed	A Clinical Study That Will Measure How Well SEP-363856 Works and How Safe it is in Adults With Generalized Anx NCT05729373	Otsuka Pharmaceutical Development & Commercialization, Inc.	Phase 2 / Phase 3
Completed	Generalized Anxiety Therapy Effectiveness NCT05748652	Big Health Inc.	N/A
Completed	Feasibility and ML Training Investigation of the Senseye DT for Diagnosis of Adults with PTSD NCT05717439	Senseye, Inc.	—
Unknown	Virtual Reality for Generalized Anxiety Disorders NCT05895721	Clinical Research Centre, Malaysia	N/A
Completed	Level of Physical Activity and Fear Learning NCT05203731	NYU Langone Health	N/A
Recruiting	Where We All Meet: ACT Approach to Adolescents Anxiety Disorders NCT05906849	University of Coimbra	N/A
Completed	Internet Delivered Cognitive Behavior Therapy Based on Intolerance of Uncertainty NCT05820568	Karolinska Institutet	N/A
Recruiting	CO2 Reactivity as a Biomarker of Non-Response to Exposure-Based Therapy NCT05467683	University of Texas at Austin	N/A
Completed	Computerized Intervention Targeting the Error-Related Negativity and Balance N1 in Anxious Children NCT05503017	Florida State University	N/A
Recruiting	Electroclinical Correlation of Anxiety NCT05393518	University Hospital, Bordeaux	N/A
Active Not Recruiting	Clinical Trial of a Group Self-management Support Program for Anxiety Disorders NCT05124639	Université de Sherbrooke	N/A
Unknown	Augmenting Mental Health Support Through a Supportive Text Messaging Program NCT05411302	Vincent Agyapong	N/A
Recruiting	Respiratory Training in the Treatment of Transdiagnostic Pathological Anxiety NCT05427708	University of Texas at Austin	N/A
Completed	Dietary Counselling Plus Omega-3 Supplementation in the Treatment of Generalized Anxiety Disorder NCT05573672	The Canadian College of Naturopathic Medicine	Phase 2
Completed	Clinical Markers of Panic and Generalized Anxiety Disorder NCT06071819	University of Milano Bicocca	—
Recruiting	BreathinG-induced Myocardial and Cerebral Perfusion in Anxiety Disorders NCT05574140	McGill University Health Centre/Research Institute of the McGill University Health Centre	—
Completed	Comparing the Efficacy of Two Neurofeedback Protocols for Generalized Anxiety Disorder NCT06361953	Shahid Beheshti University of Medical Sciences	N/A
Terminated	rTMS Pilot for Anxiety NCT05306977	University of Pennsylvania	N/A
Completed	Digital Interventions As an Add-on Tool in Generalized Anxiety Disorder Treatment NCT05375851	Hospital de Clinicas de Porto Alegre	N/A
Completed	Internet-Based, Parent-Led Cognitive-Behavioral Therapy for Anxiety in Youth With ASD NCT05284435	Baylor College of Medicine	N/A
Active Not Recruiting	Transdiagnostic Versus Diagnosis-specific Cognitive-behavioral Therapy NCT05249543	Karolinska Institutet	N/A
Active Not Recruiting	Treatment of Anxiety Disorders With Trigeminal Nerve Stimulation NCT04931134	Dr. Rafael Freire	N/A
Recruiting	Mindful Self-Compassion for Anxiety Disorders and Depression NCT05671419	Georgetown University	N/A
Recruiting	Validating an Autonomous Interactive Internet-Based Delivery of an Empirically Supported Cognitive Behavioral NCT05117255	University of Minnesota	N/A
Unknown	Triage Survey for Psychiatry Research Eligibility NCT05800925	Adams Clinical	—
Active Not Recruiting	Physical Exercise as Adjunctive Therapy for Affective Disorder and Anxiety NCT05157386	Region Stockholm	—
Unknown	Cannabidiol for the Treatment of Anxiety Disorders: An 8-Week Pilot Study NCT03549819	McMaster University	Phase 3
Recruiting	MBSR Mechanisms in GAD NCT05064813	NYU Langone Health	N/A
Terminated	Empower Neuromodulation System - Pilot Study for Anxiety Treatment NCT04901481	Theranova, L.L.C.	N/A
Unknown	Acceptability/Feasibility of IU Intervention NCT05172427	Ohio University	N/A
Withdrawn	A Study To Assess Adverse Events and Change in Disease Activity With Oral Cariprazine When Added to Antidepres NCT04965272	AbbVie	Phase 2
Completed	Digital Therapeutic for Major Depressive Disorder (MDD) and Generalized Anxiety Disorder (GAD) NCT05016050	Happify Inc.	N/A
Recruiting	Low-Intensity Focused Ultrasound Pulsation (LIFUP) for the Treatment of Generalized Anxiety Disorder (GAD) NCT04557891	University of California, Los Angeles	N/A
Completed	Parent-based Treatment for Youth With Anxiety and Obsessive-compulsive Disorder NCT04922502	Baylor College of Medicine	N/A
Recruiting	Evaluation of Primary Care Behavioral Health (PCBH) With the Addition of Self-help CBT - A Randomized Multicen NCT04900064	Linnaeus University	N/A
Completed	Decision Aid for Patients With Generalized Anxiety Disorder: Protocol for a Randomized Controlled Trial NCT04364958	Servicio Canario de Salud	N/A
Completed	Improving Attentional and Cognitive Control in the Psychological Treatment of Intrusive Thoughts NCT04225624	Massachusetts General Hospital	N/A
Active Not Recruiting	Patient-centered Treatment of Anxiety After Low-Risk Chest Pain in the Emergency Room NCT04811521	Indiana University	N/A
Completed	Comparing the Efficacy of E-CBT to Mental Health Coaching for GAD NCT04754438	Dr. Nazanin Alavi	N/A
Withdrawn	Cannabinoids for the Treatment of Anxiety Disorders: An 8-Week Pilot Study NCT04569760	McMaster University	Phase 3
Active Not Recruiting	Internet-delivered Cognitive Behavioral Treatment of Depression and Anxiety in Latin American College Students NCT04780542	Instituto Nacional de Psiquiatría Dr. Ramón de la Fuente	N/A
Terminated	Cognitive Behavioral Therapy Group for Older Adults Delivered by Telethealth NCT04714164	Nova Scotia Health Authority	N/A
Suspended	Group CBT for Intolerance of Uncertainty NCT04512378	University of Manitoba	N/A
Completed	Optimizing Cognitive Remediation NCT04395157	VA Office of Research and Development	—
Active Not Recruiting	Brain Stimulation & Generalized Anxiety Study NCT04751864	ProofPilot	Phase 4
Completed	Evaluation of Effects of CBD Products on Anxiety Among U.S. Women NCT05108220	Radicle Science	—
Unknown	An Augmented Training Program for Preventing Post-Traumatic Stress Injuries Among Diverse Public Safety Person NCT05530642	University of Regina	N/A
Recruiting	A Transdiagnostic, Self-guided Internet Intervention ("Velibra") for Waitlist Patients With Anxiety Disorders NCT04793828	Charite University, Berlin, Germany	N/A
Completed	Computerized Cognitive Training in Middle-Aged Adults With Generalized Anxiety Disorder: A Pilot Study NCT04421690	University of Missouri-Columbia	N/A
Completed	Anxiety Symptoms in Relation to Use of Hemp-derived, Full Spectrum Cannabidiol (CBD) NCT05023759	Formula30A LLC	—
Completed	Efficacy of Online CBT for GAD Compared to Pharmaceutical Interventions NCT04478526	Dr. Nazanin Alavi	N/A
Completed	Transdiagnostic Internet-delivered REBT Intervention for Adolescents' Internalizing Problems NCT04179526	Babes-Bolyai University	N/A
Unknown	Physical and Psychological Health Trajectories in the Context of Coronary Heart Disease NCT04433832	Laval University	—
Completed	Parent-Led Cognitive-Behavioral Teletherapy for Anxiety in Youth With ASD NCT04111874	Baylor College of Medicine	N/A
Recruiting	Risk and Resiliency Factors in the RCMP: A Prospective Investigation NCT05527509	University of Regina	N/A
Completed	A 14 Week, Randomized, Placebo-Controlled Cross-Over Study of Methylphenidate Hydrochloride Controlled Release NCT03785223	McMaster University	Phase 4
Unknown	Floatation-REST (Reduced Environmental Stimulation Therapy) for Anxiety and Depression NCT03899090	Laureate Institute for Brain Research, Inc.	N/A
Unknown	RECOVERY: A Transdiagnostic Intervention for Anxiety and Depression NCT03917550	West University of Timisoara	N/A
Completed	Self-help Guided by Lay Providers for Anxiety in Older Adults NCT03768544	Laval University	N/A
Completed	Music Therapy and Dialysis: A Pilot Investigation Into the Effectiveness of Patient-Selected Music Interventio NCT03925168	Tulane University	N/A
Completed	Randomized Trial of Adult Participants With Generalized Anxiety Disorder NCT03829241	Biohaven Pharmaceuticals, Inc.	Phase 3
Completed	Self-selected or Predetermined Internet-based Treatment for Generalized Anxiety Disorder With Different Types NCT03807193	Linkoeping University	N/A
Completed	Stepped-Care Cognitive-Behavioral Treatment for Youth With ASD and Anxiety NCT03720795	Baylor College of Medicine	N/A
Terminated	Treatment of Adults With Generalized Anxiety Disorder Using Glutamine NCT04274114	Hospital Universitario Dr. Jose E. Gonzalez	Phase 2
Completed	Walking or High Intensity Exercise for Anxiety NCT03819426	NYU Langone Health	N/A
Recruiting	Brief Smartphone Treatment Study NCT04846777	Penn State University	N/A
Terminated	Transcranial Pulse Near-Infrared Light in Generalized Anxiety Disorder: a Placebo-Controlled Study NCT03420456	Massachusetts General Hospital	N/A
Completed	Open Trial of an ACT Skills Group and Mobile App for Worry NCT03709433	Utah State University	N/A
Completed	Pharmacogenomic-Guided Antidepressant Drug Prescribing in Cancer Patients NCT03674138	H. Lee Moffitt Cancer Center and Research Institute	N/A
Completed	Brain Response Associated With Parent-based Treatment for Childhood Anxiety Disorders NCT03585010	Yale University	N/A
Unknown	Improving Access to Child Anxiety Treatment NCT03528109	Bradley Hospital	N/A
Completed	Treatments for Anxiety: Meditation and Escitalopram NCT03522844	Georgetown University	Phase 4
Completed	Cognitive-behavioral Therapy for Generalized Anxiety Disorder in Primary Care NCT03621371	Karolinska Institutet	N/A
Completed	Predicting Treatment Response to Exposure Therapy Using Carbon Dioxide NCT03925987	Laureate Institute for Brain Research, Inc.	N/A
Terminated	Echinacea Angustifolia (AnxioCalm) in Anxiety NCT03463018	EuroPharma, Inc.	Phase 2
Completed	The Role of Cognitive Control in the Transdiagnostic Conceptualization of "Intrusive Thoughts" NCT03414619	Massachusetts General Hospital	N/A
Completed	SkillJoy Clinical Trial NCT05040061	Skidmore College	N/A
Completed	Pharmacogenomic Testing to Optimize Antidepressant Drug Therapy NCT03591224	John Papastergiou Pharmacy Ltd	N/A
Completed	Adapting an Effective CBT for Comorbidity to a Computer-Delivered Format NCT03300232	University of Minnesota	N/A
Completed	Bioequivalence Study of Paroxetine Tablets and Paxil® Under Fasting and Fed Conditions in Chinese Healthy Volu NCT03504475	Beijing Tongren Hospital	Phase 1
Unknown	Rumination Focus Cognitive Behavior Therapy NCT03507114	West University of Timisoara	N/A
Completed	6-Session Treatment for Generalized Anxiety Disorder NCT03433625	Universite du Quebec en Outaouais	N/A
Completed	Collabri Flex - Effect of Collaborative Care for People With Anxiety Disorders in General Practice NCT03113175	Amager Hospital	N/A
Completed	Internet-delivered CBT for Adolescents With GAD NCT03469453	Karolinska Institutet	N/A
Completed	Pragmatic Collaborative Care for Cardiac Inpatients With Depression or Anxiety NCT03118752	Massachusetts General Hospital	N/A
Completed	Pilot Study of Virtual Reality for Providing Exposure Therapy to Children NCT03208348	Minnesota HealthSolutions	N/A
Unknown	Pharmacogenetics in Primary Care Psychotropics NCT03232502	University of Arizona	Phase 3
Completed	The Modular Protocol for Mental Health (MPMH) NCT03143634	Medical Research Council Cognition and Brain Sciences Unit	Phase 1 / Phase 2
Unknown	Simplified Cognitive Behavioral Therapy for Generalized Anxiety Disorder and Depression NCT03329287	Shanghai Mental Health Center	N/A
Completed	Transcutaneous Vagus Nerve Stimulation in Private Healthcare Center NCT03440255	Kinesis Health Associates	N/A
Completed	Effect of Mindfulness Meditation on Physiological Response to Unpredictable Stimuli NCT03206437	Georgetown University	N/A
Unknown	Effectiveness & Cost-effectiveness of Internet-delivered Interventions for Depression and Anxiety Disorders in NCT03188575	Silver Cloud Health	N/A
Completed	Improving Access to the Treatment of Anxiety and Depression Among Young Adults NCT03156556	Universite de Moncton	N/A
Completed	Implementation of Psychological Treatment in Generalized Anxiety NCT03079336	University of Zurich	N/A
Completed	Examining the Effects of Reduced Environmental Stimulation on Anxiety NCT03051074	Laureate Institute for Brain Research, Inc.	N/A
Completed	Dimensional Brain Behavior Predictors of CBT Outcomes in Pediatric Anxiety NCT02810171	University of Michigan	N/A
Completed	Randomized Clinical Trial of a Mindfulness Based Intervention in Generalized Anxiety Disorder NCT03072264	Hospital de Clinicas de Porto Alegre	N/A
Completed	Cognitive Behavioural Therapy for Anxiety Disorders in PD NCT02648737	Maastricht University Medical Center	N/A
Completed	Clinical Trial of Transdiagnostic Cognitive-Behavior Therapy for Anxiety Disorders NCT02811458	Université de Sherbrooke	N/A
Completed	Approach-Avoidance Conflict-a Multi-level Predictor for Therapy Response NCT02807480	Laureate Institute for Brain Research, Inc.	N/A
Completed	Short-Term Efficacy and Mechanisms of Change of a Worry Postponement Intervention for Generalized Anxiety Diso NCT02806271	Toronto Metropolitan University	N/A
Completed	Transdiagnostic REBT Prevention Program for Adolescents NCT02756507	Babes-Bolyai University	N/A
Completed	Visual Mismatch Negativity in Attention Bias Modifcation Treatment for Anxiety NCT03016052	Tel Aviv University	N/A
Unknown	Internet-delivered Transdiagnostic Intervention for Anxiety and Depression NCT02739607	West University of Timisoara	N/A
Unknown	Efficacy and Safety Study of a IMSS Developed Phytopharmaceutical for the Treatment of Anxiety. NCT03702803	Coordinación de Investigación en Salud, Mexico	Phase 2
Active Not Recruiting	Physical Exercise Augmented CBT for GAD NCT02690441	Solli Distriktspsykiatriske Senter	N/A
Completed	Efficacy of an Acceptance-based Group Behavioral Therapy for Generalized Anxiety Disorder. NCT03930095	University of Sao Paulo General Hospital	N/A
Completed	Emotion Regulation Therapy for Clinical Worry and Rumination NCT04060940	Douglas Mennin	N/A
Completed	Kava for the Treatment of Generalised Anxiety Disorder: A Double-Blind Randomised Placebo-Controlled Trial NCT02219880	University of Melbourne	Phase 4
Completed	Neural Basis of Meal Related Interoceptive Dysfunction in Anorexia Nervosa NCT02615119	Laureate Institute for Brain Research, Inc.	N/A
Completed	A Single-Component CBT for GAD NCT02552108	Universite du Quebec en Outaouais	N/A
Withdrawn	Worry Exposure for Generalized Anxiety Disorder NCT02382224	University of Texas at Austin	N/A
Unknown	Initial Severity and Antidepressant Efficacy for Anxiety Disorders: an Individual Patient Data Meta-analysis NCT02476136	prof. Peter de Jonge	—
Completed	Transdiagnostic Psychotherapy for Veterans With Mood and Anxiety Disorders NCT01947647	VA Office of Research and Development	N/A
Terminated	POC Study in Partially Responsive Generalized Anxiety Disorder NCT02310568	Pfizer	Phase 2
Completed	Cognitive Training for Mood and Anxiety Disorders NCT02256566	Icahn School of Medicine at Mount Sinai	N/A
Completed	Internet-delivered Treatment for Children With Anxiety Disorders in a Rural Area; an Open Trial in a Clinical NCT02306356	Karolinska Institutet	N/A
Completed	Transdiagnostic iCBT for Depression and Anxiety NCT02266693	Centre for Addiction and Mental Health	N/A
Completed	A Feasibility Study of Group Metacognitive Therapy Versus Mindfulness Meditation Therapy NCT02096484	University of Manchester	N/A
Terminated	Treatment of Pediatric Anxiety Disorders by Predicting Treatment Response Through Biocellular Markers and Slee NCT02189213	New York State Psychiatric Institute	N/A
Terminated	Acoustic Neuromodulation (ANM) for Youth With Anxiety Disorders NCT02572973	Weill Medical College of Cornell University	N/A
Terminated	Transcranial Magnetic Stimulation Treatment for Generalized Anxiety Disorder NCT01815099	Hartford Hospital	N/A
Completed	Psychotherapy for Anxiety in Children With Autism Spectrum Disorder NCT02028247	University of South Florida	N/A
Completed	Brief Behavioral Treatment for Anxiety in Young Children NCT02051192	University of South Florida	Phase 1 / Phase 2
Completed	GATE: Generalized Anxiety - A Treatment Evaluation NCT01912287	NYU Langone Health	N/A
Terminated	Web-based Attention Bias Modification Treatment for Childhood Anxiety Disorders NCT03764644	Erasmus Medical Center	N/A
Terminated	Attention Bias Modification Treatment for Anxious Youth NCT01979263	Weill Medical College of Cornell University	N/A
Completed	The Effects of Emotional Exposure on State Anxiety NCT03458702	Texas Tech University	N/A
Completed	Testing Beliefs About Uncertainty in the Treatment of Generalized Anxiety Disorder NCT01958788	Concordia University, Montreal	N/A
Completed	Exposure-Focused Family-Based CBT for Youth With ASD and Comorbid Anxiety NCT01919970	University of South Florida	N/A
Unknown	Attention Retraining for Anxiety Disorder Patients Resistent to Antidepressants NCT01906268	Hospital de Clinicas de Porto Alegre	N/A
Completed	Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder NCT01844115	Forest Laboratories	Phase 3
Completed	An Open Label Study of Clinical Utility and Patient Outcomes of the Genecept Assay NCT01507155	Genomind, LLC	N/A
Completed	Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder NCT01766401	Forest Laboratories	Phase 3
Completed	Efficacy of SNRI Treatment on Prefrontality in Patients With GAD and Other Comorbities NCT01975480	START Clinic for Mood and Anxiety Disorders	Phase 4
Completed	Effectiveness of Six Sessions CBT for Adolescents With Emotional Problems in Community Clinics NCT02150265	University of Tromso	N/A
Completed	Calmer Life: Testing the Effectiveness of a Treatment for Anxiety NCT01702220	Baylor College of Medicine	N/A
Completed	Cognitive-Behavioral Treatment and Interpretation Modification Training for Adults With Generalized Anxiety Di NCT01681329	Concordia University, Montreal	N/A
Completed	Locating Regions of Interest in Generalized Anxiety Disorder Using Function Magnetic Resonance Imaging (fMRI) NCT01607710	Hartford Hospital	—
Completed	Safety, Efficacy and Tolerability of Vilazodone in Generalized Anxiety Disorder NCT01629966	Forest Laboratories	Phase 3
Completed	Transcranial Magnetic Stimulation Treatment for Generalized Anxiety Disorder NCT01659736	Hartford Hospital	N/A
Completed	Computer- Assisted Cognitive-Behavioral Treatment for Anxiety Disorders in Children With Autism Spectrum Disor NCT01565629	University of South Florida	N/A
Completed	Online Treatments for Mood and Anxiety Disorders in Primary Care NCT01482806	University of Pittsburgh	Phase 2 / Phase 3
Completed	Tandospirone Citrate in the Treatment of Patients With Generalized Anxiety Disorder NCT01614041	Sumitomo Pharma (Suzhou) Co., Ltd.	Phase 4
Completed	Motivational Interviewing and Cognitive Behavioural Therapy for Generalized Anxiety Disorder NCT01488799	York University	N/A
Completed	Internet-based Treatment of Generalized Anxiety Disorder NCT01570374	Umeå University	N/A
Completed	Treatment Study for Rural Latino Youth With Anxiety NCT01491880	University of California, San Diego	Phase 1 / Phase 2
Unknown	Combination of Active or Placebo Attentional Bias Modification Treatment (ABMT) to Either Cognitive Behavioral NCT01687764	Hospital de Clinicas de Porto Alegre	N/A
Completed	Computerized Cognitive Behavioral Therapy for Childhood Anxiety in Community Health Centers NCT01416805	University of South Florida	Phase 3
Completed	Cognitive Behavioral Therapy for Anxiety Disorders in Adolescents With Autism NCT01563003	University of South Florida	N/A
Completed	A Clinical Trial to Study the Effects of Sensoril® for Patients With Generalized Anxiety Disorder NCT01311180	Natreon, Inc.	Phase 2
Completed	Electronic Self-management Resource Training for Mental Health NCT01304862	Case Western Reserve University	N/A
Completed	Telephone Psychotherapy for Late-Life Generalized Anxiety Disorder (GAD) NCT01259596	Wake Forest University Health Sciences	N/A
Completed	A Study of Duloxetine in Elderly Generalized Anxiety Disorder NCT01118780	Eli Lilly and Company	Phase 4
Completed	Efficacy of Massage Therapy in the Treatment of Generalized Anxiety Disorder (GAD) NCT01337713	Emory University	N/A
Completed	A Collaborative Care Program to Improve Treatment of Depression and Anxiety Disorders in Cardiac Patients NCT01201967	Massachusetts General Hospital	Phase 4
Completed	PHARMO Institute Seroquel Safety Study NCT01342120	AstraZeneca	—
Completed	Brain Markers of Anxiety Disorders and SSRI/CBT Treatment in Children and Adolescents NCT01160588	University of Michigan	—
Completed	False Safety Behavior Elimination Therapy: A Randomized Study of a Brief Individual Transdiagnostic Treatment NCT02082561	Florida State University	N/A
Completed	Stress Reduction and Anxiety: Effects on the Function and Structure of the Brain NCT01128309	Massachusetts General Hospital	N/A
Completed	Cognitive-Behavioral Treatment for Anxiety Disorders in Children With Autism Spectrum Disorders NCT01178385	University of South Florida	Phase 2 / Phase 3
Completed	Ziprasidone in Bipolar Disorder With Comorbid Lifetime Panic or Generalized Anxiety Disorder(GAD) NCT01172652	VA Palo Alto Health Care System	Phase 4
Completed	Long Term Chamomile Therapy for Anxiety NCT01072344	University of Pennsylvania	Phase 3
Terminated	Generalized Anxiety and Seroquel NCT01066143	Mclean Hospital	N/A
Active Not Recruiting	Outcomes of Cognitive Behavioral Therapy (CBT) Interventions Provided by Unlicensed Professionals NCT01075672	Massachusetts General Hospital	N/A
Completed	An Open Label Trial of Duloxetine in the Treatment of Irritable Bowel Syndrome and Comorbid Generalized Anxiet NCT00961298	West Penn Allegheny Health System	Phase 4
Completed	Cognitive Behavioral Therapy (CBT) for Latinos With Generalized Anxiety Disorder in the General Medical Sector NCT01203293	University of Puerto Rico	Phase 1
Completed	Efficacy of Extended-release Quetiapine (Seroquel XR) as Adjunctive Therapy to Cognitive Behavioral Therapy in NCT01971203	Icahn School of Medicine at Mount Sinai	N/A
Completed	Exercise Training for the Treatment of Generalized Anxiety Disorder NCT00953654	University of Georgia	N/A
Unknown	Mechanisms of Sleep Disturbance in Children With Generalized Anxiety Disorder (GAD) NCT01032473	Children's National Research Institute	—
Completed	Comparing Different CBT Approaches in GAD NCT03650465	Babes-Bolyai University	N/A
Completed	Safety and Efficacy Evaluation Of Pregabalin (Lyrica) With Patients With Generalized Anxiety Disorder NCT00624780	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	Phase 4
Completed	Escitalopram in Patients With Generalized Anxiety Disorder NCT00902564	H. Lundbeck A/S	Phase 4
Completed	Sleep, Mood, and Behavior Study NCT00787397	University of Pittsburgh	N/A
Terminated	Investigation Of How PD 0332334 And Metformin Are Eliminated From The Body When They Are Administered At The S NCT00809536	Pfizer	Phase 1
Completed	Psychodynamic Internet Treatment Versus Cognitive Behavioral Therapy (CBT) for Generalized Anxiety Disorder NCT01312116	Linkoeping University	N/A
Terminated	Evaluating The Effects Of Cimetidine On The Elimination Of PD 0332334 From The Body NCT00800280	Pfizer	Phase 1
Withdrawn	6-Month Open-Label Safety Study Of PD 0332334 In Elderly Patients With Generalized Anxiety Disorder (GAD) NCT00738738	Pfizer	Phase 3
Completed	The Comparative Clinical Study of Gamisoyosan on Anxiety of Generalized Anxiety Disorder According to Dosage F NCT01285115	Korea Health Industry Development Institute	Phase 3
Completed	Duloxetine for the Treatment of Generalized Anxiety Disorder NCT00803361	Eli Lilly and Company	Phase 3
Completed	Relapse-prevention Study With Lu AA21004 (Vortioxetine) in Patients With Generalized Anxiety Disorder NCT00788034	H. Lundbeck A/S	Phase 3
Terminated	A 52-Week Open-Label Safety Study of PD 0332334 in Subjects With Generalized Anxiety Disorder (GAD) NCT00735267	Pfizer	Phase 3
Completed	Transdisciplinary Studies of CBT for Anxiety in Youth: Child Anxiety Treatment Study NCT00774150	University of Pittsburgh	N/A
Completed	Study of the Changes in Metabolic Parameters in Patients Treated With Escitalopram for Six Months NCT00711737	Changi General Hospital	—
Completed	Efficacy and Safety of Vortioxetine (Lu AA21004) for Treatment of Generalized Anxiety Disorder in Adults. NCT00744627	Takeda	Phase 3
Terminated	Open-Label Pilot Study to Examine the Value of Substituting Quetiapine for Benzodiazepines NCT01244711	Weill Medical College of Cornell University	Phase 4
Completed	Effectiveness of Cognitive Behavioral Therapy (CBT) for Child Anxiety Disorders in Community Clinics in Norway NCT00735995	Regionsenter for barn og unges psykiske helse	Phase 2
Completed	Quetiapine in Co-Morbid Depressive and Anxiety Disorders NCT00688818	Centre for Addiction and Mental Health	N/A
Completed	Efficacy of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety Disorder NCT00730691	Takeda	Phase 3
Completed	Study of Efficacy and Safety of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety Disorder NCT00731120	Takeda	Phase 3
Terminated	Quetiapine Extended Release (XR) Treatment of Major Depressive Disorder With Comorbid Generalized Anxiety Diso NCT00868374	Keming Gao	Phase 3
Completed	An Efficacy and Safety Study of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety Disorder NCT00734071	Takeda	Phase 3
Terminated	A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 for the Treatment of Generalized Anxiety Diso NCT00658762	Pfizer	Phase 3
Terminated	A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 in Patients With Generalized Anxiety Disorder NCT00658372	Pfizer	Phase 3
Completed	Cognitive Behavior Treatment of Older Adults With Generalized Anxiety Disorder in Primary Care NCT00765219	Baylor College of Medicine	N/A
Terminated	A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 in Patients With Generalized Anxiety Disorder NCT00658008	Pfizer	Phase 3
Completed	Drug Treatment Validation of Functional Magnetic Resonance Imaging in Generalized Anxiety Disorder NCT00662259	University of California, San Diego	Phase 4
Completed	Stress Reduction Techniques and Anxiety: Therapeutic and Neuroendocrine Effects NCT01033851	Massachusetts General Hospital	Phase 4
Completed	Exploratory Study to Evaluate the Effect of SYN111 (Rufinamide) in Patients With Generalized Anxiety Disorder NCT00595231	Biotie Therapies Inc.	Phase 2
Completed	Virtual Reality as Anxiety Management Tool for Generalized Anxiety Disorder NCT00602212	Istituto Auxologico Italiano	N/A
Completed	Effectiveness Study of CBT for Anxiety in Children NCT00586586	Haukeland University Hospital	Phase 2
Completed	rTMS Treatment in Patients With General Anxiety Disorder NCT00616447	Queen's University	N/A
Completed	Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Sub NCT00616655	Sumitomo Pharma America, Inc.	Phase 2
Terminated	Anxiety in Recovering Opiate Dependence NCT00668265	Beth Israel Medical Center	Phase 4
Completed	Attention Training for Generalized Anxiety Disorder NCT00602563	San Diego State University	N/A
Completed	ERP N1 as a Treatment Predictor of Generalized Anxiety Disorder NCT00613067	Inje University	N/A
Completed	Neural Functioning Underlying Anxiety and Its Treatment (The INSULA Study) NCT00947570	University of California, San Diego	N/A
Completed	Antidepressant Treatment Plus Cognitive Behavioral Therapy for Generalized Anxiety Disorder in Older Adults NCT00601965	Veterans Medical Research Foundation	N/A
Completed	A 10-Week Study Evaluating the Efficacy And Safety of PD 0332334 for the Treatment of Generalized Anxiety Diso NCT00542685	Pfizer	Phase 3
Completed	An Open-label Study to Investigate the Absorption, Metabolism and Excretion of Radiolabeled PD 0332334 in Six NCT00537615	Pfizer	Phase 1
Completed	Therapeutic Massage for Generalized Anxiety Disorder NCT00515242	Kaiser Permanente	Phase 1 / Phase 2
Completed	Evaluating the Effects of Stress in Pregnancy NCT00525226	Emory University	—
Completed	Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder NCT00481325	Bristol-Myers Squibb	Phase 2 / Phase 3
Unknown	Brain Imaging and Computer Games in Children With Either Bipolar Disorder, ADHD, Anxiety or Healthy Controls NCT01570426	Bradley Hospital	—
Completed	Quetiapine SR and Divalproex Sodium ER in the Treatment of Anxiety in Bipolar Disorder With Panic Disorder and NCT00579280	University of South Florida	Phase 4
Completed	CBT for GAD: Impact of Cognitive Processing on Treatment Outcome NCT03099772	Concordia University, Montreal	N/A
Completed	RCT of an Acceptance-based Behavior Therapy for GAD NCT00961493	University of Massachusetts, Boston	N/A
Completed	Comparing Cognitive Behaviour Therapy (CBT) With Metacognitive Therapy (MCT) in the Treatment of GAD NCT00426426	Norwegian University of Science and Technology	N/A
Completed	Pregabalin in the Treatment of Patients With Generalized Anxiety Disorder (GAD). NCT00413010	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	Phase 3
Completed	Combined Treatment for Generalized Anxiety Disorder (GAD) NCT00620776	University of Pennsylvania	Phase 2
Completed	Efficacy and Safety of Pregabalin vs Placebo for Generalized Anxiety Disorder (GAD) Symptoms in Subjects Disco NCT00368745	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	Phase 3
Completed	Repetitive Magnetic Transcranial Stimulation (rTMS) in the Treatment of Generalized Anxiety Disorder (GAD) NCT00662584	University of California, Los Angeles	Phase 3
Completed	Primary Care Intervention Strategy for Anxiety Disorders NCT00347269	University of Washington	Phase 4
Completed	Efficacy of Treatment for Generalized Anxiety Disorder NCT00456742	University of British Columbia	—
Completed	Efficacy and Safety Study of Seroquel SR in the Treatment of Generalized Anxiety Disorder NCT00322595	AstraZeneca	Phase 3
Completed	Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Generalized Anxiety Disorder NCT00329264	AstraZeneca	Phase 3
Completed	Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo & Active Control in Generalized Anxiety NCT00329446	AstraZeneca	Phase 3
Completed	Acamprosate in Alcoholics With Comorbid Anxiety or Depression NCT00330174	Medical University of South Carolina	Phase 4
Completed	Treatment of Late-life Anxiety in Primary Care Settings NCT00938093	Wake Forest University Health Sciences	N/A
Terminated	Ziprasidone for the Treatment of Generalized Anxiety in Patients With Bipolar Disorder NCT00374543	Massachusetts General Hospital	Phase 4
Completed	Trial of Seroquel SR for Alcohol Dependence and Comorbid Anxiety NCT00352469	Creighton University	Phase 4
Completed	A 5-Week Trial Of PD 0332334 And Alprazolam Extended Release Compared To Placebo In Patients With Generalized NCT00921063	Pfizer	Phase 2
Completed	Chamomile Therapy for Generalized Anxiety NCT00645983	University of Pennsylvania	Phase 4
Completed	Trial to Compare Time to Response in the Symptoms of Anxiety to Concomitant Treatment With Niravam™ and an SSR NCT00266409	UCB Pharma	Phase 4
Completed	Pharmacological Treatment of Generalized Anxiety Disorder in the Elderly NCT00701675	VA Office of Research and Development	Phase 4
Completed	A Pilot Study of Cranial Electrotherapy Stimulation[CES] for Generalized Anxiety Disorder NCT00539357	University of California, Los Angeles	Phase 4
Completed	Black Cohosh as Alternative Therapy for Treating Menopause-Related Anxiety NCT00120458	University of Pennsylvania	Phase 4
Completed	Safety and Efficacy of Eszopiclone in Patients With Generalized Anxiety Disorder NCT00235508	Sumitomo Pharma America, Inc.	Phase 4
Completed	Memantine Treatment for Obsessive-compulsive Disorder and Generalized Anxiety Disorder NCT00674219	University of California, Los Angeles	Phase 3
Completed	Aripiprazole for the Treatment of Refractory Anxiety NCT00438386	Massachusetts General Hospital	Phase 4
Completed	Cognitive-Behavioral Therapy and Escitalopram for Generalized Anxiety Disorder(GAD) NCT00219349	New York State Psychiatric Institute	Phase 4
Completed	Drug Therapy for Generalized Anxiety Disorder Among the Elderly NCT00105586	University of Pittsburgh	Phase 4
Completed	A 10-Week Efficacy and Safety Study for of Gabitril in the Treatment of Adults With Generalized Anxiety Disord NCT00236054	Cephalon	Phase 3
Completed	A 10-Week Study for Efficacy and Safety Study of Gabitril in the Treatment of Adults With Generalized Anxiety NCT00236067	Cephalon	Phase 3
Completed	Treating Late-Life Generalized Anxiety Disorder (GAD) in Primary Care NCT00308724	Baylor College of Medicine	N/A

Showing the 300 most recent trials. Use search for older records.